İstanbul Journal of Pharmacy

SUBMITINFORMATION
EnglishTürkçe

Research Article


DOI :10.26650/IstanbulJPharm.2022.1018698   IUP :10.26650/IstanbulJPharm.2022.1018698    Full Text (PDF)

Design, synthesis and biological evaluation of novel sulfonamide hydrazones as α-glucosidase and α-amylase inhibitors

Çağla Begüm Apaydın, Gözde Hasbal Çelikok, Tuğba Yılmaz Özden, Gökçe Cihan Üstündağ

Background and Aims: Diabetes mellitus is among the major hazards to global public health due to increasing incidence worldwide, and new therapeutic agents are urgently needed for the control of the disease. In this study, a novel series of sulfonamide hydrazones (3a-i) were synthesized and evaluated, in vitro, for α-amylase and α-glucosidase inhibitor activities. Methods: Target compounds were prepared according to a high-yielded synthetic route. The in vitro antidiabetic activity of the compounds was analyzed by evaluating the inhibitory abilities on α-glucosidase and α-amylase enzymes. Acarbose was chosen as a reference in this study. Results: Compounds 3d, 3e, 3g and 3h exhibited better α-glucosidase inhibitory activity compared to reference antidiabetic drug acarbose. Compound 3g was the most active analogue, possessing an IC50 value of 65.27 µg/mL. 3d, 3e, 3g and 3h showed similar α-amylase inhibitory activity compared to acarbose when tested at high concentrations. However, their IC50 values were much higher compared to that of reference acarbose. Conclusion: The most active analogue 3g was found to be two times more active than acarbose. The addition of a bulky group to the 4-position of the cyclohexane ring seemed to have a positive effect on antidiabetic activity. The new hydrazone derivatives reported in this study are potentially promising candidates for developing new antidiabetic agents.

Keywords: Antidiabetic activity, Sulfonamide, Hydrazone, α-amylase, α-glucosidase

PDF View

References

  • Akkurt, M., Türktekin-Çelikesir, S., Cihan-Üstündağ, G., Çapan, G., & Büyükgüngör, O. (2013). N-(4-Ethylcyclohexylidene)-5-fluoro-3-phenyl-1H-indole-2-carbohydrazide. Acta Crystallographica Section E, E69, 1331. https://doi.org/10.1107/S1600536813020394 google scholar
  • Ali, H., Houghton, P J., & Soumyanath, A. (2006). a-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with partic-ular reference to Phyllanthus amarus. Journal of Ethnopharmacology, 107(3), 449-455. https://doi.org/10.1016/jjep.2006.04.004 google scholar
  • Apaydın, Ç.B. (2018). Fenoksiasetamid Yapısı Taşıyan Tiyazolidinonlar Üzerinde Çalışmalar. (Doctoral dissertation). Retrieved from https://tez.yok. gov.tr/UlusalTezMerkezi/tezDetay.jsp?id=MsUfCzS3veHBGNDkm8m_ BA&no=91GPEzP_U0xS5UJCmhRx8A google scholar
  • Bothon, F. T. D., Debiton, E., Avlessi, F., Forestier, C., Teulade, J. C., & Sohounhloue, D. K. C. (2013). In vitro biological effects of two anti-diabetic medicinal plants used in benin as folk medicine. BMC Complementary and Alternative Medicine, 13(51), 1-8. https:// doi.org/10.1186/1472-6882-13-51 google scholar
  • Cihan-Üstündağ, G. & Çapan, G. (2012). Synthesis and evaluation of functionalized indoles as antimycobacterial and anticancer agents. Molecular Diversity,16, 525-539. https://doi.org/10.1007/ s11030-012-9385-y google scholar
  • Cihan-Üstündağ, Mataracı-Kara, E., & Çapan, G. (2019). Synthe-sis, characterization, antibacterial and antifungal evaluation of novel cyclohexanone benzoylhydrazones. Istanbul Journal of Pharmacy, 49(3), 142-147. https://doi.org/10.26650/Istan-bulJPharm.2019.19022 google scholar
  • DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J. ...Weiss, R. (2015). Type 2 diabetes mellitus. Na-ture Reviews Disease Primers, 1, 1-23. https://doi.org/10.1038/ nrdp.2015.19 google scholar
  • Hossain, U., Das, A. K., Ghosh, S., & Sil, P. C. (2020). An overview on the role of bioactive a-glucosidase inhibitors in ameliorating dia-betic complications. Food and Chemical Toxicology, 145, 111738. https://doi.org/10.1016/j.fct.2020.111738 google scholar
  • Kocabalkanlı, A.,Cihan-Üstündağ, G., Naesens, L., Mataracı-Kara, E., Nassozi, M., & Çapan, G. (2017). Diclofenac-Based hydrazones and spirothiazolidinones: Synthesis, Characterization, and antimicro-bial properties. Archieve der Pharmazie, 350, e1700010. https://doi. org/10.1002/ardp.201700010 google scholar
  • Koçyiğit-Kaymakçıoğlu, B., Elçin, O., Seda, U., Fatma, K., Nathaly, S., Sevim, R., & Dimoglo, A. (2006). Synthesis and characterization of novel hydrazide-hydrazones and the study of their structure-an-tituberculosis activity. European Journal of Medicinal Chemistry, 41(11), 1253-1261. https://doi.org/10.1016/j.ejmech.2006.06.009 google scholar
  • Liu, Z., & Ma, S. (2017). Recent Advances in Synthetic a-Glucosidase Inhibitors. ChemMedChem, 12(11), 819-829. https://doi.org/10.1002/cmdc.201700216 google scholar
  • Metwally, K. A., Abdel-Aziz, L. M., Lashine, E. S. M., Husseiny, M.I., & Badawy, R. H. (2006). Hydrazones of 2-aryl-quinoline-4-car-boxylic acid hydrazides: Synthesis and preliminary evaluation as antimicrobial agents. Bioorganic and Medicinal Chemistry, 14(24), 8675-8682. https://doi.org/10.1016/j.bmc.2006.08.022 google scholar
  • Moldovan, C. M., Oniga, O., Pârvu, A., Tiperciuc, B., Verite, R, Pîrnâu, A. . Pop, R. (2011). Synthesis and anti-inflammatory evalua-tion of some new acyl-hydrazones bearing 2-aryl-thiazole. Euro-pean Journal of Medicinal Chemistry, 46(2), 526-534. https://doi. org/10.1016/j.ejmech.2010.11.032 google scholar
  • Montalvo-Gonzalez, R., Montalvo-Gonzalez, J.A., & Ariza-Castolo, A. (2008). Conformational and structural analysis of exocyclic olefins and ketimines by multinuclear magnetic resonance. Magnetic Res-onance in Chemistry, 46, 907-917. https://doi.org/10.1002/mrc.2259">https://doi.org/10.1002/mrc.2259 Nasr, T., Bondock, S., & Youns, M. (2014). Anticancer activity of new coumarin substituted hydrazide-hydrazone derivatives. Eu-ropean Journal of Medicinal Chemistry, 76, 539-548. https://doi. org/10.1016/j.ejmech.2014.02.026 google scholar
  • Padhi, S., Nayak, A.K., & Behera, A. (2020). Type II diabetes mellitus: a review on recent drug based therapeutics. Biomed Pharmaco-ther, 131, 110708. doi:10.1016/j.biopha.2020.110708 google scholar
  • Proença, C., Ribeiro, D., Freitas, M., & Fernandes, E. (2021). Flavo-noids as potential agents in the management of type 2 diabetes through the modulation of a-amylase and a-glucosidase activity: a review. Critical Reviews in Food Science and Nutrition, https://doi. org/10.1080/10408398.2020.1862755 google scholar
  • Taha, M., Ismail, N. H., Javaid, K., Imran, S., Anouar, E. H., Wadood, A. . Choudhary, M. I. (2015). Evaluation of 2-indolcarbohydra-zones as potent a-glucosidase inhibitors, in silico studies and DFT based stereochemical predictions. Bioorganic Chemistry, 63, 24-35. https://doi.org/10.1016/j.bioorg.2015.09.001 google scholar
  • Toniolo, A., Cassani, G., Puggioni, A., Rossi, A., Colombo, A., On-odera, T., & Ferrannini, E. (2019). The diabetes pandemic and as-sociated infections: Suggestions for clinical microbiology. Reviews in Medical Microbiology, 30(1), 1-17. https://doi.org/10.1097/ MRM.0000000000000155 google scholar
  • Türktekin-Çelikesir, S., Akkurt, M., Cihan-Üstündağ, G., Çapan, G., & Büyükgüngör, O. (2013). 5-Fluoro-N0-(4-methylcyclohexylidene)-3-phenyl-1H-indole-2-carbohydrazide. Acta Crystallographica Sec-tion E, E69, 1211-1212. https://doi//10.1107/S1600536813018436 Ulusoy Güzeldemirci, N., Şatana, D., & Küçükbasmacı, Ö. (2015). Synthesis and antimicrobial evaluation of some new hydrazone derivatives of 6-(4-nitrophenyl)imidazo[2,1-b]thiazole-3-aceticac-id hydrazide. Istanbul Journal of Pharmacy, 45(2), 127-138. google scholar
  • Ulusoy Güzeldemirci, N., Pehlivan, E., Halamoğlu, Z., & Koca-balkanli, A. (2016). Synthesis and antiviral activity evaluation of some new cyclohexylidenehydrazide derivatives of 1,3-thiazole core. Marmara Pharmaceutical Journal, 20, 207-215. https://doi. org/10.12991/mpj.20162019913 google scholar
  • Wang, G., Chen, M., Wang, J., Peng, Y., Li, L., Xie, Z. Z. . Li, W. (2017). Synthesis, biological evaluation and molecular docking studies of chromone hydrazone derivatives as a-glucosidase inhibitors. Bioorganic and Medicinal Chemistry Letters, 27(13), 2957-2961. https://doi.org/10.1016/j.bmcl.2017.05.007 google scholar
  • World Health Organization (2021). WHO Health topics:Diabetes. Re-trieved from https://www.who.int/health-topics/diabetes#tab=tab_1 Zawawi, N. K. N. A., Taha, M., Ahmat, N., Wadood, A., Ismail, N. H., Rahim, F. . Abdullah, N. (2016). Benzimidazole derivatives as new a-glucosidase inhibitors and in silico studies. Bioorganic Chemis-try, 64, 29-36. https://doi.org/10.1016/j.bioorg.2015.11.006 google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Apaydın, Ç., Hasbal Çelikok, G., Yılmaz Özden, T., & Cihan Üstündağ, G. (2022). Design, synthesis and biological evaluation of novel sulfonamide hydrazones as α-glucosidase and α-amylase inhibitors. İstanbul Journal of Pharmacy, 52(2), 108-113. https://doi.org/10.26650/IstanbulJPharm.2022.1018698


AMA

Apaydın Ç, Hasbal Çelikok G, Yılmaz Özden T, Cihan Üstündağ G. Design, synthesis and biological evaluation of novel sulfonamide hydrazones as α-glucosidase and α-amylase inhibitors. İstanbul Journal of Pharmacy. 2022;52(2):108-113. https://doi.org/10.26650/IstanbulJPharm.2022.1018698


ABNT

Apaydın, Ç.; Hasbal Çelikok, G.; Yılmaz Özden, T.; Cihan Üstündağ, G. Design, synthesis and biological evaluation of novel sulfonamide hydrazones as α-glucosidase and α-amylase inhibitors. İstanbul Journal of Pharmacy, [Publisher Location], v. 52, n. 2, p. 108-113, 2022.


Chicago: Author-Date Style

Apaydın, Çağla Begüm, and Gözde Hasbal Çelikok and Tuğba Yılmaz Özden and Gökçe Cihan Üstündağ. 2022. “Design, synthesis and biological evaluation of novel sulfonamide hydrazones as α-glucosidase and α-amylase inhibitors.” İstanbul Journal of Pharmacy 52, no. 2: 108-113. https://doi.org/10.26650/IstanbulJPharm.2022.1018698


Chicago: Humanities Style

Apaydın, Çağla Begüm, and Gözde Hasbal Çelikok and Tuğba Yılmaz Özden and Gökçe Cihan Üstündağ. “Design, synthesis and biological evaluation of novel sulfonamide hydrazones as α-glucosidase and α-amylase inhibitors.” İstanbul Journal of Pharmacy 52, no. 2 (May. 2024): 108-113. https://doi.org/10.26650/IstanbulJPharm.2022.1018698


Harvard: Australian Style

Apaydın, Ç & Hasbal Çelikok, G & Yılmaz Özden, T & Cihan Üstündağ, G 2022, 'Design, synthesis and biological evaluation of novel sulfonamide hydrazones as α-glucosidase and α-amylase inhibitors', İstanbul Journal of Pharmacy, vol. 52, no. 2, pp. 108-113, viewed 18 May. 2024, https://doi.org/10.26650/IstanbulJPharm.2022.1018698


Harvard: Author-Date Style

Apaydın, Ç. and Hasbal Çelikok, G. and Yılmaz Özden, T. and Cihan Üstündağ, G. (2022) ‘Design, synthesis and biological evaluation of novel sulfonamide hydrazones as α-glucosidase and α-amylase inhibitors’, İstanbul Journal of Pharmacy, 52(2), pp. 108-113. https://doi.org/10.26650/IstanbulJPharm.2022.1018698 (18 May. 2024).


MLA

Apaydın, Çağla Begüm, and Gözde Hasbal Çelikok and Tuğba Yılmaz Özden and Gökçe Cihan Üstündağ. “Design, synthesis and biological evaluation of novel sulfonamide hydrazones as α-glucosidase and α-amylase inhibitors.” İstanbul Journal of Pharmacy, vol. 52, no. 2, 2022, pp. 108-113. [Database Container], https://doi.org/10.26650/IstanbulJPharm.2022.1018698


Vancouver

Apaydın Ç, Hasbal Çelikok G, Yılmaz Özden T, Cihan Üstündağ G. Design, synthesis and biological evaluation of novel sulfonamide hydrazones as α-glucosidase and α-amylase inhibitors. İstanbul Journal of Pharmacy [Internet]. 18 May. 2024 [cited 18 May. 2024];52(2):108-113. Available from: https://doi.org/10.26650/IstanbulJPharm.2022.1018698 doi: 10.26650/IstanbulJPharm.2022.1018698


ISNAD

Apaydın, Çağla Begüm - Hasbal Çelikok, Gözde - Yılmaz Özden, Tuğba - Cihan Üstündağ, Gökçe. “Design, synthesis and biological evaluation of novel sulfonamide hydrazones as α-glucosidase and α-amylase inhibitors”. İstanbul Journal of Pharmacy 52/2 (May. 2024): 108-113. https://doi.org/10.26650/IstanbulJPharm.2022.1018698



TIMELINE


Submitted03.11.2021
Accepted26.04.2022
Published Online29.08.2022

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.